Regeneron Therapeutics INC

Regeneron Therapeutics INC

Biotechnology Research

Hayward, CA 133 followers

Pioneering affordable genetic medicines for inherited diseases. Join our revolution in healthcare.

About us

At Regeneron Therapeutics, we're dedicated to making genetic medicines accessible. As a startup gene therapy company, we're committed to developing an AI-driven platform for personalized treatments targeting inherited retinal diseases and neurodegenerative conditions. Our goal is to create affordable, long-lasting gene therapies through research, production, and commercialization. Founded by visionary PhD students, professors, patients, and ophthalmologists, we believe collaboration is key to advancing genetic medicine. Our mission is to ensure that genetic treatments are affordable for all patients worldwide. We're challenging the high costs of gene therapy and revolutionizing the field with innovative technology developed at the Institute of Ophthalmology, University College London. If you're passionate, ingenious, and resilient, join us in transforming healthcare.

Website
https://www.regeneron-therapeutics.com/
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Hayward, CA
Type
Privately Held
Founded
2023
Specialties
opthalmology, genetic therapy, non-viral vector, platform medicine, Platform medicine, neurology, and Affordable genetic medicines

Locations

  • Primary

    Bonneville Lab, Hayward O1-7, 25801 Industrial Blvd

    Hayward, CA 94545, US

    Get directions

Employees at Regeneron Therapeutics INC

Updates

Similar pages